The CONSENSUS-LAI Study: Establishing Shared Definitions of Virological Failure and Discontinuation for Long-Acting Injectable Cabotegravir and Rilpivirine Therapy
Chloe Orkin,Amy Paterson,Alexa Elias,Melanie Smuk,Kyle Ring,Alain Volny-Anne,Alexandra Calmy,Anna Maria Geretti,Aniruddha Hazra,Asa E. Radix,Boghuma K. Titanji,Spire Bruno,Caroline Foster,Carolyn Bolton Moore,Carlos del Rio,Claudia P. Cortes,Cristina Mussini,Daniel Kuritzkes,Darrell Hoi-San Tan,Esteban Martínez,Ferdinand Wit,Fiona Cresswell,Francois Venter,Itzchak Levy,Jason Zucker,Jean-Michel Molina,Jennifer Hoy,José R. Arribas,Josep M. Llibre,Judith S. Currier,Jürgen K. Rockstroh,Jussi Sutinen,Kelly Gebo,Laura Waters,Magnus Gisslen,Mark O&aposReilly,Marta Boffito,Melanie Thompson,Milosz Parczewski,Mina John,Monica Gandhi,Nagalingeswaran Kumarasamy,Nicholas Paton,Nicola Mackie,Pedro Cahn,Rick Elion,Sebastian Noe,Sharon Walmsley,Simon Collins,Susan Cole-Haley,Vanessa Apea,William R. Short,Yvonne Gilleece,Sara Paparini
